Shah Gaurav Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$483,113.00
Insider Sells Quantity
11
Insider Sells Sum
$4.29M

Insider Activity of Shah Gaurav

According to the SEC Form 4 filings, Shah Gaurav, being in a position of

  1. CEO at Rocket Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 90496 shares for $285,667,
    over all time since 2019-03-01, has bought 42000 shares for $483,113, and sold 334359 shares for $4.61M.

Biography of Shah Gaurav

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$285,6678100

Comparison of Insiders on Amount of Buys and Sells

2026-08-18SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
2,293
0.0021%
$3.38$7,753-21.26%
2026-08-13SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
2,837
0.0025%
$3.38$9,592-19.46%
2026-05-21SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
55,684
0.0506%
$3.09$171,841+5.31%
2026-05-19SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
2,409
0.0023%
$3.01$7,261+11.64%
2026-05-13SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
2,728
0.0025%
$3.61$9,837-9.72%
2026-02-18SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
5,990
0.0054%
$3.34$19,995+0.58%
2026-02-13SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
12,279
0.0115%
$3.31$40,668+6.12%
2025-11-18SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
6,276
0.0059%
$2.98$18,721+17.69%
2025-05-20SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
2,253
0.002%
$6.45$14,523-50.8%
2025-05-16SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
3,621
0.0034%
$6.53$23,638-47.85%
2025-04-10PurchaseRocket Pharmaceuticals, Inc.
RCKT
CEO
20,000
0.0184%
$5.08$101,600-31.17%
2025-02-21SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
16,303
0.0149%
$10.58$172,486-67.53%
2024-11-21SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
11,091
0.0122%
$13.05$144,782-66.73%
2024-08-16SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
9,650
0.0105%
$18.50$178,564-46.65%
2024-05-16SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
9,790
0.0108%
$23.35$228,597-34.85%
2024-02-16SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
20,272
0.0224%
$29.84$604,876-34.52%
2023-08-17SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
4,767
0.006%
$15.47$73,750+49.9%
2023-05-17SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
4,122
0.0051%
$21.38$88,108+4.85%
2023-02-17SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
12,194
0.015%
$19.06$232,418+2.36%
2022-02-07PurchaseRocket Pharmaceuticals, Inc.
RCKT
CEO
22,000
0.0339%
$17.34$381,513-6.75%
Total: 23
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.